
Pawan Kumar Sharma MD
Adult Congenital Heart Disease, Interventional Cardiology
Physician
Join to view full profile
1160 E 3900 SSte 2000Salt Lake City, UT 84124
Phone+1 801-266-3418
Fax+1 801-288-4444
Dr. Sharma is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Utah HealthFellowship, Cardiovascular Disease, 1996 - 2000
University of Tennessee College of Medicine at ChattanoogaResidency, Internal Medicine, 1993 - 1996
Maulana Azad Medical CollegeClass of 1980
Certifications & Licensure
UT State Medical License 1996 - 2026
WY State Medical License 2021 - 2025
FL State Medical License 2000 - 2016
AL State Medical License 1995 - 2015
TN State Medical License 1995 - 1996
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2013-2017
Publications & Presentations
PubMed
- 53 citationsA decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors.Amit Kumar, Kiran Siwach, Claudiu T Supuran, Pawan K Sharma
Bioorganic Chemistry. 2022-09-01 - 21 citationsTail-approach based design and synthesis of Arylthiazolylhydrazono-1,2,3-triazoles incorporating sulfanilamide and metanilamide as human carbonic anhydrase I, II, IV a...Amit Kumar, Kiran Siwach, Tanmay Rom, Rajiv Kumar, Andrea Angeli
Bioorganic Chemistry. 2022-06-01 - 26 citationsTail approach synthesis of novel benzenesulfonamides incorporating 1,3,4-oxadiazole hybrids as potent inhibitor of carbonic anhydrase I, II, IX, and XII isoenzymes.Vikas Sharma, Rajesh Kumar, Andrea Angeli, Claudiu T. Supuran, Pawan K. Sharma
European Journal of Medicinal Chemistry. 2020-05-01
Press Mentions
Blood Test Offers New Hope for People with Depression, BipolarNovember 29th, 2021
MP Hospital Performs Gruelling and Rare 12-Hour Liver Surgery on Man with Congenital DiseaseSeptember 13th, 2021
Delhi Govt Launches ‘Vaccination on Wheels’ to Inoculate Labourers Against COVID-19September 6th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









